Phenibut Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about Phenibut dosing — protocols, safety, and where to buy.
Half-Life
5-8 hours (plasma); central CNS effect 10-16 hours
Administration Routes
Dosage Calculator
Calculate exact dosing for Phenibut.
Dosing Protocols
Beginner-friendly phenibut protocol — occasional situational use only.
Before starting: read the full contraindications and side-effects sections above. Phenibut is not a routine nootropic — it is a GABAergic with meaningful dependence liability that requires careful use patterns. If you are considering phenibut for daily anxiety management, do not start; see a clinician about first-line anxiolytics instead.
Step 1 — Source verification. Obtain phenibut HCl (most common form; more stable, less bitter than free-amino-acid form) from a vendor that provides a third-party certificate of analysis (HPLC identity and purity). Do not take any "phenibut" capsule or powder without COA verification; adulterated products have been documented.
Step 2 — First-dose test (in a safe setting). Take 250 mg (one-quarter to one-half of a typical 500-1000 mg capsule, depending on product) in the morning on a day with no obligations requiring driving, operating machinery, or important decision-making. Take with food to slow absorption. Wait 3-4 hours for peak effect. Notice: mild relaxation, slight reduction in background anxiety, possibly mild sedation. The first-dose effect is usually subtle — do not re-dose to chase a stronger effect.
Step 3 — Effective dose finding (subsequent single doses, minimum 7 days between). If 250 mg was tolerated and produced mild beneficial effects, consider 500 mg as a situational dose 2-4 hours before a specific anticipated stressor (a social event, a flight, an exam, a medical procedure-related anxiety). Do not combine with alcohol. Do not drive for at least 8-12 hours after the dose. Expect residual effect for 8-12 hours, with mild next-day grogginess possible.
Step 4 — Frequency limit. Absolute maximum for beginner use: once per week with at least 7 days between doses. This is a harm-reduction limit to prevent tolerance and dependence — it is not a "target" frequency. Less frequent use is better. Many responsible users take phenibut no more than 4-6 times per year.
Step 5 — Self-monitoring. Keep a written log of every dose (date, amount, situation, effects, next-day impact). Watch for any of the following red flags: thinking about the next dose between doses; wanting to increase frequency; using it for non-situational reasons (just to "feel good" on a normal day); needing it to sleep; using it after a social event rather than before; combining with alcohol. Any of these is a signal to stop and reassess — not to continue with discipline.
What NOT to do as a beginner:
- Do not take phenibut more than once per week.
- Do not exceed 500 mg on a single occasion without substantial experience.
- Do not combine with alcohol, benzodiazepines, opioids, or other CNS depressants.
- Do not take phenibut to manage day-to-day anxiety — this is a daily-use pattern that leads to dependence.
- Do not take phenibut recreationally at high doses (1500+ mg). The margin of safety narrows rapidly above 1 gram, and the subjective effect becomes more intoxication than anxiolysis.
- Do not take phenibut before sleep as a routine sleep aid. Use is appropriate only for specific, occasional situations.
- Do not redose within the same day. Onset is slow (2-4 hours); waiting to feel the first dose and stacking a second dose has led to multiple over-sedation events.
When to stop. Any sign of escalating frequency, preoccupation with future doses, or use during non-situational times means stop immediately. Early stopping is easy; stopping after 2-4 weeks of daily use is not.
Intermediate phenibut protocol — for users with established tolerance and demonstrated responsible use patterns.
This tier assumes: you have taken phenibut 5+ times previously at beginner doses, you have never used more than once per week for sustained periods, you have no history of dependence on benzodiazepines, alcohol, or other GABAergic substances, you understand the withdrawal profile, and you have a clear non-daily use case.
Typical situational dose: 500-1000 mg phenibut HCl, taken 2-4 hours before the anticipated stressor. At 1000 mg, expect clearly noticeable anxiolysis, mild euphoria, reduced social anxiety, and some motor impairment. Do not drive for 12-16 hours. Expect next-day subjective "fog" that may be noticeable but is usually mild.
Frequency limit: Maximum twice per week with minimum 72 hours between doses, and no more than 6 days in any 30-day period. This is a harm-reduction maximum, not a target. Most intermediate users find that even this is more than they actually want once they are calibrated to the next-day effect.
Timing for specific use cases:
- Social anxiety at a scheduled event: 500-750 mg, 3-4 hours before, with food. Plan transportation home (do not drive).
- Pre-flight anxiety: 500 mg 2-3 hours before departure. If the flight is >6 hours, do not re-dose. If using for overnight flights, consider that phenibut-induced sleep can be oddly unrefreshing.
- Dental / medical procedure anxiety: Coordinate with the procedure's anaesthesia team — phenibut can interact with sedatives and anaesthetics. Many clinicians prefer that patients not self-medicate before procedures.
- Important presentation or exam: Most experienced users avoid phenibut for cognitive-demanding performance tasks because the sedative component can blunt sharpness. Propranolol (if prescribed for performance anxiety) or l-theanine are often better choices.
Forbidden combinations (absolute): alcohol, benzodiazepines, opioids (including tramadol and codeine), GHB/GBL, baclofen, kratom, z-drugs, first-gen antihistamines at high doses.
Tolerance management at this tier: If you notice the effect of your usual dose diminishing, do not increase the dose. Take a 30-60 day break to reset. Escalation of dose is the classic signature of developing dependence.
Self-monitoring heuristics:
- Am I thinking about my next phenibut dose between uses? (Red flag.)
- Am I using phenibut in response to stress rather than for a specific event? (Red flag.)
- Am I hiding my use from partner / friends / clinician? (Red flag.)
- Do I feel I "need" phenibut to get through a social situation I used to manage without it? (Red flag.)
- Has my usual dose stopped producing the subjective effect I expect? (Tolerance is developing; stop entirely.)
Interactions to verify before dosing: If you have started any new prescription medication, verify with a pharmacist that it has no CNS-depressant or sedating effect before taking phenibut. If you are on an SSRI or SNRI, phenibut does not have a direct pharmacokinetic interaction, but the behavioural pattern of combining them is a common pathway to dependence.
Next-day recovery: Hydration, protein-containing breakfast, caffeine if tolerated, and light movement (walk, stretching) help mitigate the post-dose grogginess. The effect typically resolves by 24-36 hours after dosing. Avoid making significant decisions in the 12-hour post-dose window.
Advanced phenibut use is almost never a good idea.
This section does not contain instructions for escalating phenibut use. The honest advanced framing is that responsible long-term phenibut users converge toward less frequent use, not more — the compound's therapeutic-to-toxic ratio narrows with dose and frequency, and there is no advanced technique that changes this fundamental pharmacology.
The advanced-tier reality check:
- If you have been using phenibut more than twice a month for over 6 months, you are not an "advanced user" — you are in the early stages of dependence. The longer this pattern has continued, the harder the exit ramp.
- Daily use is not an advanced protocol; it is a dependence pattern requiring medical taper.
- "Cycling" phenibut (5 days on, 2 days off, etc.) does not prevent tolerance or dependence — it simply delays and obscures them.
- High doses (>1500 mg) are not an "advanced tolerance"; they are escalation indicative of either tolerance-driven use or poorly managed recreational use.
What advanced responsible use actually looks like:
- Using phenibut for no more than 4-10 specific, identifiable occasions per year, with careful documentation of each use.
- A typical "advanced" user has phenibut in their kit but uses it less often than a beginner, because the novelty has worn off and they have better tools for their common stressors.
- Preference for non-phenibut alternatives (propranolol for performance anxiety, l-theanine for mild daily calm, CBT skills for social anxiety, occasional benzodiazepine under clinician supervision when truly warranted) as first-line.
Managing accidental escalation:
If you have drifted into more-than-planned phenibut use — say, 4-5 days a week for a month — you are at moderate risk for withdrawal on abrupt cessation. The appropriate response is:
- Stop escalating immediately; hold current dose.
- Begin a measured taper: reduce daily dose by 10-15% every 3-7 days. For a user at 1500 mg/day, that's roughly 150-250 mg reduction per step, with each step held for at least a week before further reduction.
- Consider a bridge medication. Many clinicians use a short baclofen taper (same receptor, easier pharmacokinetics, better tolerated withdrawal) or a gabapentin bridge. This requires a prescriber.
- If symptoms of significant withdrawal emerge (tachycardia > 100, tremor, significant insomnia, autonomic instability, perceptual changes), seek medical attention — a benzodiazepine/phenobarbital-facilitated taper in a clinical setting is appropriate for severe cases.
- Address the underlying anxiety that drove escalation. Phenibut was not solving it; it was deferring it.
The exit ramp is easier early. The single most important advanced-use principle is that stopping at the first sign of escalation is much easier than stopping after it is established. If you notice the pattern changing, stop; do not continue "just for this one more stressful week."
For anyone helping a family member or friend. Phenibut dependence is under-recognised by general-practice clinicians because the drug is not in most drug screens and because the withdrawal syndrome can be mistaken for anxiety relapse or alcohol withdrawal. If you suspect phenibut dependence in someone you know, the most useful thing you can do is help them connect with an addiction medicine specialist familiar with benzodiazepine and baclofen tapers — the same clinical skills apply.
Alternatives that scale better with long-term use:
- For chronic anxiety: SSRI or SNRI (sertraline, escitalopram, venlafaxine) plus CBT. Much larger evidence base, no dependence.
- For performance anxiety: Propranolol 10-40 mg 30-60 min before the event. Not a controlled substance in most jurisdictions, well-characterised safety, no tolerance development.
- For mild daily stress: L-theanine 200 mg, ashwagandha 300-600 mg, meditation, exercise, sleep optimisation.
- For acute situational anxiety requiring pharmacotherapy: Short-course benzodiazepine under medical supervision with clear limits on duration.
- For sleep: CBT-I, sleep hygiene, melatonin for circadian issues, short-term z-drugs or trazodone under clinician supervision.
Each of these is supported by much stronger evidence than phenibut for its respective indication and does not carry the same dependence liability.
Commonly Stacked With
Phenibut's stacking profile is dominated by one overriding rule: avoid combining it with any other CNS depressant, full stop. Within that constraint, there are a small number of legitimate combinations and several commonly proposed stacks that range from pointless to dangerous.
Combinations to AVOID absolutely:
- Alcohol. Additive GABAergic and respiratory depression. This combination is responsible for a substantial fraction of phenibut-related emergency presentations and deaths in the forensic literature. Even "just a drink or two" with a phenibut dose can produce unpredictable over-sedation. Treat as an absolute contraindication.
- Benzodiazepines (alprazolam, diazepam, lorazepam, clonazepam, etc.). Additive GABA-A and indirect GABA-B effects, with high risk of over-sedation and respiratory depression. Also, benzodiazepines can mask early signs of phenibut tolerance/dependence.
- Opioids (codeine, tramadol, oxycodone, hydrocodone, heroin, fentanyl). Synergistic respiratory depression. High fatality risk.
- Baclofen. Direct GABA-B agonist with much higher potency per milligram — combining the two produces unpredictable additive effects. Baclofen has legitimate use in managed phenibut taper, but self-dosing both simultaneously is inappropriate.
- GHB / sodium oxybate / GBL / 1,4-BDO. All converge on GABA-B agonism. Combining creates risk of overdose at doses that would be safe for either alone.
- Z-drugs (zolpidem, zopiclone, eszopiclone). Additive sedation.
- First-generation antihistamines (diphenhydramine, doxylamine) at high doses. Additive sedation and anticholinergic burden.
- Kava. Additive GABAergic sedation.
- Kratom. Additive CNS depression, poorly characterised synergy.
Combinations with caution:
- SSRIs and SNRIs. Pharmacokinetically compatible. The main caution is that SSRIs can produce initial activation/anxiety that users may be tempted to "cover" with phenibut — this creates a pattern of dependence that is hard to unwind. If you are on an SSRI for anxiety or depression, adding phenibut is generally not a good idea.
- Buspirone. Different mechanism (5-HT1A partial agonism), pharmacokinetically compatible, but combining is rarely necessary. Buspirone is often a better choice than phenibut for chronic anxiolysis.
- Propranolol. Peripheral beta-blockade for performance anxiety can be combined with phenibut for pre-presentation anxiety in individuals who understand the risks, but this is a situational combination, not a daily regimen.
- Caffeine. Can offset phenibut sedation in the first hours after dosing. Be aware that this combination can produce an uncomfortable "stimulant + depressant" feel for some users, and it can mask the awareness of phenibut-induced motor impairment.
Combinations commonly discussed in the nootropic community:
- Phenibut + l-theanine. Synergistic anxiolysis at modest doses. L-theanine adds a calming, alpha-wave-promoting effect without additional dependence risk. This is probably the single most common phenibut stack and is considered relatively safe at low doses.
- Phenibut + ashwagandha. Both target anxiety through different mechanisms (phenibut at GABA-B, ashwagandha via HPA-axis modulation). Pharmacokinetically compatible, though ashwagandha has its own cautions in certain populations.
- Phenibut + magnesium glycinate. Magnesium has mild NMDA antagonism and GABAergic-potentiating effects, and may attenuate phenibut-associated tension headaches. Pharmacokinetically compatible.
- Phenibut + noopept or racetams. Commonly discussed as a "cognitive anxiolytic" stack. The racetam component does not meaningfully alter phenibut pharmacology but may partially offset next-day grogginess for some users.
- Phenibut + 5-htp or tryptophan. Pharmacokinetically compatible but not especially synergistic. Primarily layering independent mood-supportive interventions.
Avoid adding phenibut to taper protocols. Do not use phenibut to help taper off alcohol, benzodiazepines, or other GABAergic substances — you are effectively swapping one dependence for another with unpredictable cross-tolerance dynamics. Proper tapers should be clinician-supervised with appropriate medications.
Avoid phenibut as a "daily anxiolytic." The phrase "I just take a little phenibut every morning for my anxiety" is the first sentence of a dependence narrative. Any pattern of daily or near-daily use is inappropriate for this compound. If your anxiety requires daily management, see a clinician — there are far better chronic anxiolytic options.
Cycling guidance. For occasional situational use, common harm-reduction schedules are: (a) no more than once per week with minimum 4-day gaps; (b) no more than 2 days per week with 3-day gaps; (c) never more than 3 days in any 2-week period. Any pattern more frequent than this rapidly escalates dependence risk.
Side Effects & Safety
Contraindications
**Absolute contraindications (do not use):** - Active alcohol use disorder or recent heavy alcohol use. - Current benzodiazepine, barbiturate, GHB, or baclofen use or dependence. - Opioid use disorder or current opioid therapy (including tramadol, codeine-containing products). - Pregnancy, breastfeeding, or active efforts to conceive (for either partner — data too sparse to support any "safe" use). - Age under 18 (Russian paediatric indications exist but should not be generalised to casual use in minors). - Severe renal impairment (CrCl <30 mL/min). - Severe hepatic impairment. - Known hypersensitivity to phenibut or related compounds. - Active treatment for any substance use disorder. - History of phenibut dependence or withdrawal. - Within 12-24 hours of planned driving, operation of heavy machinery, or any safety-critical task. **Relative contraindications (use with substantial caution or avoid):** - Personal history of anxiety disorder severe enough to require daily pharmacotherapy (use a first-line anxiolytic instead). - Personal history of sleep disorders requiring regular sedative use. - History of seizure disorder (phenibut withdrawal can precipitate seizures). - History of depressive disorder (phenibut can produce next-day low mood; can interact with the emotional substrate of depression in non-helpful ways). - History of attention-deficit / hyperactivity disorder treated with stimulants (phenibut + stimulants produce unpredictable subjective effects; do not layer without understanding). - Concurrent SSRI, SNRI, or tricyclic antidepressant therapy (no direct pharmacokinetic interaction, but behavioural risk of substituting phenibut for addressing the underlying mood/anxiety condition). - Age over 65 (reduced metabolic capacity, increased fall and fracture risk, prolonged half-life). - Any occupation where impaired judgment or motor control has safety implications (pilots, drivers, surgeons, heavy-equipment operators). - History of eating disorders (phenibut has been misused to manage food-related anxiety and disordered eating patterns). **Behavioural red flags that preclude continued use:** - Thinking about or planning the next dose between uses. - Escalation of dose or frequency beyond planned pattern. - Using in response to generalised stress rather than for a specific anticipated event. - Using after the fact rather than before (e.g., after a bad day rather than before a known-stressful event). - Hiding use from partner, family, or clinician. - Using to get through social situations previously navigated without it. - Combining with alcohol, benzodiazepines, or other CNS depressants. - Ordering more than a small supply at a time (a year's worth of genuinely occasional use is 5-20 doses). - Using from a vendor without third-party certificates of analysis. Any of these is a sign to stop immediately. The window between "occasional responsible use" and "dependence that requires clinical taper" is narrow and easily missed. **Withdrawal-related contraindications.** If you have been taking phenibut daily for more than 1-2 weeks at any meaningful dose, do not stop abruptly. Seizures, delirium, and severe autonomic instability have been reported. Taper over 2-6 weeks, ideally with clinician support. This is the same principle that applies to benzodiazepines. **Legal status.** Phenibut is illegal to sell, possess, or import in some jurisdictions (Australia — Schedule 9; UK — controlled under Psychoactive Substances Act; Hungary — scheduled). It is unscheduled in the US but the FDA has stated that it does not meet the definition of a dietary supplement. Legal status does not correlate with safety — "legal in your jurisdiction" does not mean "safe to use daily." Know the local regulation before sourcing. **Medical consultation strongly recommended.** Particularly for anyone with a history of mental health conditions, substance use, or on concurrent medications, discussing phenibut use with a clinician — even a clinician unfamiliar with it — is valuable. Many primary care physicians in the US can look up the pharmacology quickly and give useful cautions. Pharmacists are particularly helpful for interaction screening.
Additional Notes
Reference dose ranges (approximate, for oral phenibut HCl):
- Sub-threshold / familiarisation: 250 mg. Mild effect, useful for first-time dosing to assess tolerance. Often subjectively "underwhelming" but diagnostically useful — a clear response at 250 mg suggests you are a strong responder and should stay at lower doses.
- Typical situational dose: 500-750 mg. Moderate anxiolysis, mild sedation, clearly noticeable effect at 3-4 hours post-dose.
- Higher situational dose: 1000 mg. More pronounced effect. Motor impairment becomes clearly relevant — no driving, no machinery, no complex motor tasks. Recovery the next day is usually noticeable but not disabling.
- Recreational / high-dose: 1500-2000 mg. Not a therapeutic dose range. Significantly impaired judgment and motor function. Elevated risk of vomiting, aspiration, or blackout. Not recommended.
- Overdose / danger zone: >2500 mg, or any dose combined with alcohol/benzodiazepines/opioids. Seek medical attention if ingested.
Onset and duration. Oral phenibut HCl onset is slow — peak plasma at 2-4 hours post-dose. Subjective effect often lags another 30-60 minutes after peak plasma because of CNS distribution. Duration of clear effect is 6-10 hours, with residual effect 10-16 hours. This long, slow pharmacokinetic profile is one of the reasons redosing within the same day is dangerous: users who "don't feel anything yet" at 2 hours and take a second dose often end up overdosed at 4-5 hours when both doses have reached peak.
Timing relative to meals. Take with food to slow absorption and reduce GI upset, particularly with the free amino acid form. A protein-containing meal slows absorption slightly but does not materially reduce total exposure.
Formulations.
- Phenibut HCl: The most common form. More acidic, slightly bitter, but more stable and better-absorbed. Typical powder or capsule.
- Phenibut FAA (free amino acid): Less acidic, often described as "smoother," but less well-characterised pharmacokinetics. Doses are not interchangeable with HCl on a mg-for-mg basis — FAA doses typically need to be ~20% higher to produce comparable effect.
- Avoid liquid preparations from unknown sources. Concentration and contaminants are often poorly controlled.
Do not re-dose within the same day. This is the most common mistake. If you take 500 mg and feel "nothing" at 90 minutes, do not take another 500 mg — you have not yet reached peak effect.
Weekly and monthly limits. Regardless of dose per occasion, frequency is the dominant driver of dependence risk. A 500 mg dose used twice per week for a year will produce more tolerance and withdrawal risk than a 1000 mg dose used once a month. Keep cumulative monthly exposure low.
Special populations.
- Renal impairment: Phenibut is renally cleared. In impaired renal function, exposure is prolonged and dose should be reduced. In significant impairment, phenibut should be avoided.
- Hepatic impairment: Less concerning than renal (minimal hepatic metabolism), but care is warranted given the general principle of avoiding psychotropics in significant liver disease.
- Elderly users: Increased sensitivity to CNS depressants, prolonged half-life. Start at half the standard beginner dose, or avoid entirely in favour of better-characterised anxiolytics.
- Pregnancy and breastfeeding: Avoid. No safety data; known to cross biological barriers.
- History of alcohol use disorder, benzodiazepine dependence, or GHB use: High-risk group for phenibut misuse. Avoid.
- History of seizure disorder: Phenibut itself is not pro-convulsant at therapeutic doses, but withdrawal can precipitate seizures in vulnerable individuals. Extra caution required.
Storage. Phenibut HCl is stable at room temperature in dry conditions. Protect from moisture and direct sunlight. Keep out of reach of children and pets — a single adult dose can be dangerous for a child.
Where to Buy Phenibut
Compare 1 listing across 1 vendor — from $65.00
Frequently Asked Questions
What is the recommended Phenibut dosage?
Dosage for Phenibut varies by protocol. Consult a qualified healthcare provider.
How often should I take Phenibut?
Administration frequency depends on the specific protocol. Consult current research literature.
Does Phenibut need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are Phenibut side effects?
Phenibut's side effects fall into three categories: acute-dose effects (largely dose-dependent sedation and impairment), withdrawal effects (physiologically similar to benzodiazepine/alcohol withdrawal), and interactions with other CNS depressants (additive and potentially fatal). **Acute-dose side effects (at typical nootropic doses, 250-1000 mg).** At low doses (250-500 mg), side effects are typically mild: light-headedness, mild sedation, subjective warmth or "social ease," occasional nausea if taken on an empty stomach, mild next-day grogginess if taken late in the day. Most users report that 500 mg taken in the morning has faded to baseline by bedtime with minimal next-day effect. At moderate doses (500-1000 mg), the effect profile shifts toward more prominent sedation, mild euphoria, noticeable reduction in social anxiety, impaired reaction time and motor coordination (DO NOT DRIVE OR OPERATE MACHINERY), disinhibition (particularly in novice users), and at the high end of this range, slurred speech and impaired judgment resembling alcohol intoxication. Hangover-like effects the next day — mild grogginess, low mood, headache — are common at 1000 mg doses. At high doses (1500-3000+ mg), side effects become prominent and potentially dangerous: marked sedation, profound motor impairment, slurred speech, ataxia, impaired judgment (including impaired awareness of how impaired one is — a hallmark of GABAergic intoxication), nausea and vomiting, hypotonia, and at the top of this range, risk of loss of consciousness, respiratory depression, and aspiration. Users have reported "phenibut blackouts" with periods of amnesia resembling alcohol blackouts. This is not a therapeutic dose range and should not be targeted. **Tolerance.** Daily or near-daily dosing produces rapid tolerance to the anxiolytic and euphoric effects, with progressive escalation of dose required to achieve the same subjective effect. This is the primary pathway to dependence, and the reason harm-reduction guidance strongly recommends no more than 1-2 doses per week with 72+ hour intervals. **Withdrawal syndrome (physical dependence).** This is the most medically significant adverse effect of phenibut and the primary reason it does not belong in the same category as most other nootropics. After daily dosing for as little as 2-4 weeks at typical recreational doses (1+ g/day), abrupt cessation produces a withdrawal syndrome that typically begins 12-24 hours after the last dose and peaks over 2-5 days. Symptoms include: - Severe rebound anxiety, often far exceeding baseline - Insomnia, often near-total for 3-5 days - Autonomic instability: tachycardia, hypertension, tremor, diaphoresis - Nausea, vomiting, anorexia - Perceptual disturbances, derealisation, mild hallucinations - Myoclonic jerks - In severe cases (high-dose, prolonged use): seizures, delirium, psychotic symptoms Protracted withdrawal with persistent anxiety, insomnia, and anhedonia can last weeks to months after acute symptoms resolve, mirroring post-acute withdrawal syndromes seen with benzodiazepines and alcohol. **Do not cold-turkey phenibut.** Anyone who has been using phenibut daily for more than 2 weeks should taper slowly (typically 10% reduction every 3-7 days) and ideally under clinical supervision. In medical settings, taper is often facilitated with a cross-titration to baclofen (same primary GABA-B receptor target, longer half-life, more familiar pharmacokinetics) or with a benzodiazepine/gabapentin bridge. Self-managed cold-turkey withdrawal from daily high-dose phenibut can produce seizures and requires the same caution as benzodiazepine cold-turkey withdrawal — it is not comparable to, say, caffeine withdrawal or SSRI discontinuation. **Interaction-related effects.** Combined use with alcohol, benzodiazepines, opioids, z-drugs, or other GABAergic sedatives produces additive and sometimes synergistic CNS and respiratory depression. Several phenibut-related deaths in the forensic literature involve polydrug combinations. These combinations should be treated as contraindicated. **Common mild complaints.** Even in appropriate harm-reduction use patterns, users report occasional headache, GI upset (particularly with the free amino acid form on an empty stomach), mild rebound anxiety the day after dosing, and "emotional blunting" for 24-48 hours post-dose. **What phenibut does NOT typically cause.** Unlike stimulants, phenibut does not produce tachycardia, hypertension, or sleep disruption at therapeutic doses (the opposite — it tends to normalise or lower heart rate and promote sleep). Unlike SSRIs, it does not cause sexual dysfunction or emotional blunting with chronic use (though acute blunting is reported). Unlike antipsychotics, it does not cause movement disorders or metabolic effects. Unlike classical anxiolytics like buspirone, it has rapid onset — this is part of both its appeal and its abuse potential. **When to stop immediately and seek medical advice.** Any symptoms of dependence (needing the drug to feel normal, difficulty abstaining, escalating doses), withdrawal-like symptoms during attempted abstinence, polydrug overdose scenarios, or concerning neurological/psychiatric symptoms warrant immediate clinical evaluation. Poison control (US: 1-800-222-1222; Australia: 13 11 26) can advise on acute toxicity. For dependence, addiction medicine clinicians experienced with benzodiazepine/alcohol tapers are the appropriate specialists.
Where can I buy Phenibut?
Compare 1 listings from 1 vendor on our price comparison page — starting from $65.00.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
